Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by NISHIDA, I.
Right arrow Articles by YAMADA, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NISHIDA, I.
Right arrow Articles by YAMADA, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

J. Biochem, 1986, Vol. 99, No. 5 1447-1454
© 1986 Japanese Biochemical Society


research-article

Effect of Thiolactomycin on the Individual Enzymes of the Fatty Acid Synthase System in Escherichia coli1

Ikuo NISHIDA2, Akihiko KAWAGUCHI and Mitsuhiro YAMADA

Department of Biology, The university of Tokyo Meguro-ku, Tokyo 153

Thiolactomycin, an antibiotic with the structure of (4S)-(2E,5E)-2,4,6-trimethyl-3-hydroxy-2,5,7-octatriene-4-thiolide, selectively inhibits type II fatty acid synthases. The mode of the thiolactomycin action on the fatty acid synthase system of Escherichia coli was investigated. Of the six individual enzymes of the fatty acid synthase system, [acyl-carrier-protein] (ACP) acetyltransferase and 3-oxoacyl-ACP synthase were inhibited by thiolactomycin. On the other hand, the other enzymes were not affected by this antibiotic. The thiolactomycin inhibition of the fatty acid synthase system was reversible. As to ACP acetyltransferase, the inhibition was competitive with respect to ACP and uncompetitive with respect to acetyl-CoA. As to 3-oxoacyl-ACP synthase, the inhibition was competitive with respect to malonyl-ACP and noncompetitive with respect to acetyl-ACP. The thiolactomycin action on the fatty acid synthase system was compared with that of cerulenin.

1 This research was supported in part by Grants-in-Aid from the Ministry of Education, Science and Culture of Japan.

2 Present address: Institute of Basic Biology, Okazaki, Aichi 444.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Johansson, B. Wiltschi, P. Kumari, B. Kessler, C. Vonrhein, J. Vonck, D. Oesterhelt, and M. Grininger
Inhibition of the fungal fatty acid synthase type I multienzyme complex
PNAS, September 2, 2008; 105(35): 12803 - 12808.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-M. Zhang, S. W. White, and C. O. Rock
Inhibiting Bacterial Fatty Acid Synthesis
J. Biol. Chem., June 30, 2006; 281(26): 17541 - 17544.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Lack, E. Homberger-Zizzari, G. Folkers, L. Scapozza, and R. Perozzo
Recombinant Expression and Biochemical Characterization of the Unique Elongating beta-Ketoacyl-Acyl Carrier Protein Synthase Involved in Fatty Acid Biosynthesis of Plasmodium falciparum Using Natural and Artificial Substrates
J. Biol. Chem., April 7, 2006; 281(14): 9538 - 9546.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
X. He, A. M. Reeve, U. R. Desai, G. E. Kellogg, and K. A. Reynolds
1,2-Dithiole-3-Ones as Potent Inhibitors of the Bacterial 3-Ketoacyl Acyl Carrier Protein Synthase III (FabH)
Antimicrob. Agents Chemother., August 1, 2004; 48(8): 3093 - 3102.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. R. Kuo, H. R. Morbidoni, D. Alland, S. F. Sneddon, B. B. Gourlie, M. M. Staveski, M. Leonard, J. S. Gregory, A. D. Janjigian, C. Yee, et al.
Targeting Tuberculosis and Malaria through Inhibition of Enoyl Reductase: COMPOUND ACTIVITY AND STRUCTURAL DATA
J. Biol. Chem., May 30, 2003; 278(23): 20851 - 20859.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
X. He and K. A. Reynolds
Purification, Characterization, and Identification of Novel Inhibitors of the {beta}-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) from Staphylococcus aureus
Antimicrob. Agents Chemother., May 1, 2002; 46(5): 1310 - 1318.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
G. E. Schujman, K.-H. Choi, S. Altabe, C. O. Rock, and D. de Mendoza
Response of Bacillus subtilis to Cerulenin and Acquisition of Resistance
J. Bacteriol., May 15, 2001; 183(10): 3032 - 3040.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. F. Waller, P. J. Keeling, R. G. K. Donald, B. Striepen, E. Handman, N. Lang-Unnasch, A. F. Cowman, G. S. Besra, D. S. Roos, and G. I. McFadden
Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum
PNAS, October 13, 1998; 95(21): 12352 - 12357.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
L. Han, S. Lobo, and K. A. Reynolds
Characterization of beta -Ketoacyl-Acyl Carrier Protein Synthase III from Streptomyces glaucescens and Its Role in Initiation of Fatty Acid Biosynthesis
J. Bacteriol., September 1, 1998; 180(17): 4481 - 4486.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. Kremer, J. D. Douglas, A. R. Baulard, C. Morehouse, M. R. Guy, D. Alland, L. G. Dover, J. H. Lakey, W. R. Jacobs Jr., P. J. Brennan, et al.
Thiolactomycin and Related Analogues as Novel Anti-mycobacterial Agents Targeting KasA and KasB Condensing Enzymes in Mycobacterium tuberculosis
J. Biol. Chem., May 26, 2000; 275(22): 16857 - 16864.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.